Ampio Pharmaceuticals

Home » Ampio Pharmaceuticals

Secondary

Ampio Pharmaceuticals

Pharmaceutical

Follow-On Offering: Our focus is on developing Ampion, which is a compound that decreases inflammation by inhibiting specific pro-inflammatory compounds.

Symbol

AMPE

Last Closing Price
$0.70

Shares
35,000,000

Anticipated Date
June 17, 2019

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Ampio Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253